These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11350908)

  • 1. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
    Dai J; Shen R; Sumitomo M; Goldberg JS; Geng Y; Navarro D; Xu S; Koutcher JA; Garzotto M; Powell CT; Nanus DM
    Clin Cancer Res; 2001 May; 7(5):1370-7. PubMed ID: 11350908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
    Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
    Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth.
    Horiguchi A; Zheng R; Goodman OB; Shen R; Guan H; Hersh LB; Nanus DM
    Cancer Gene Ther; 2007 Jun; 14(6):583-9. PubMed ID: 17415380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
    Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
    Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis.
    Horiguchi A; Chen DY; Goodman OB; Zheng R; Shen R; Guan H; Hersh LB; Nanus DM
    Prostate Cancer Prostatic Dis; 2008; 11(1):79-87. PubMed ID: 17563767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
    Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the neutral endopeptidase gene promoter in human prostate cancers.
    Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM
    Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells.
    Venkataraman S; Jiang X; Weydert C; Zhang Y; Zhang HJ; Goswami PC; Ritchie JM; Oberley LW; Buettner GR
    Oncogene; 2005 Jan; 24(1):77-89. PubMed ID: 15543233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J; Isaacs JT
    Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
    Lu X; Hsieh TC; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
    Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC
    Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.